货号（Catalog No.）
CSD00139
通用名INN
Ocrelizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis. It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets the B lymphocytes that express the CD20 antigen. As a humanized molecule, ocrelizumab is expected to be less immunogenic with repeated infusions which improves the benefit-to-risk profile for patients with relapsing or progressive forms of MS.
别名(Alternative names)
2H7
靶点;物种(Specificity target name;species)
MS4A1/CD20[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-nd
化学信息
分子量(MV)
145000.00 Da
CAS
637334-45-3
存储条件(Storage)
store at -80°C
Note
For research use only .